Abstracts | DGVS/DGAV
Kurzvorträge
Molekulare Therapie bei CED Donnerstag, 18. September 2025, 11:15 – 12:51, MZF 1
M Sossdorf
1
MSD Sharp & Dohme GmbH, Munich, Deutschland
,
C Ma
2
Division of Gastroenterology & Hepatology, Departments of Medicine and Community Health
Sciences, University of Calgary, Calgary, Kanada
,
S Hoque
3
Department of Gastroenterology, Barts Health NHS Trust, London, Vereinigtes Königreich
,
M P Sparrow
4
Department of Gastroenterology, School of Translational Medicine, Monash University
and Alfred Health, Melbourne, Australien
,
J K Anderson
5
Merck & Co., Inc., Rahway, Vereinigte Staaten
,
M Yen
5
Merck & Co., Inc., Rahway, Vereinigte Staaten
,
B Dong
5
Merck & Co., Inc., Rahway, Vereinigte Staaten
,
B G Feagan
6
Departments of Medicine, Epidemiology, and Biostatistics, Western University, London,
Kanada
,
B E Sands
7
Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount
Sinai, New York, Vereinigte Staaten
› Author Affiliations
